Skip to main content
. 2016 May 23;2016(5):CD007126. doi: 10.1002/14651858.CD007126.pub3

Leykin 2008.

Methods Randomized, double‐blind, active‐controlled study
Medications administered 15 min before discontinuation of anesthesia
Participants Type of surgery: functional endoscopic sinus
Propacetamol group
Entered/completing: 25/25
Age (mean, SD): 32 ± 10
Sex (male, %): 72
Parecoxib group
Entered/completing: 25/25
Age (mean, SD): 34 ± 12
Sex (male, %): 76
Interventions Intervention: 2 g propacetamol over 15 min
Control: 40 mg IV parecoxib
Outcomes Pain intensity (VAS) and derived SPID
Opioid consumption (morphine)
Patient satisfaction (categorical)
Source of funding Not reported
Were treatment groups comparable at baseline? Yes: demographics; type of procedure. Intraoperative and postoperative hemodynamic variables also reported to be similar, but no data shown.
Details of preoperative pain Participants with chronic pain requiring major analgesics, sedatives, or corticosteroids were excluded
Notes Participants had only mild pain at baseline
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated randomization
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection bias) 
 All outcomes Low risk Study drugs mixed by physician not involved in study. Double‐dummy technique employed.
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Analyses on ITT population, but no mention of imputation method
Selective reporting (reporting bias) Low risk All outcomes from Methods section reported in Results section
Size High risk Fewer than 50 participants per arm of the study (25 propacetamol, 25 parecoxib)